Oncology Central

Treatment options for myelofibrosis and myeloproliferative neoplasia

0

Essential thrombocythemia, polycythemia vera and primary myelofibrosis belong to the Philadelphia chromosome negative (Ph-) myeloproliferative neoplasia (MPN) group of diseases. MPNs are clonal bone marrow stem cell disorders characterized by a proliferation of one or more of the myeloid, erythroid or megakaryocytic cell lines. The treatment of MPN patients should be carried out according to their risk stratification.

To view restricted content, please:
Share:

Leave A Comment